Beginning to sound like a broken record. I am enjoying seeing how the patterns more or less repeats itself within a major industry sector. Like the currencies against USD are doing a similar thing, so do major pharma stocks. Anyway, Fib goals traced, not financial advice.
☝️ Losing patent protection for a top-selling blockbuster drug is a big setback for any pharmaceutical company, but this can also give us great opportunities. They have done a great strategic-movement by acquiring Allergan. It's down 18% from last July 17 high, earnings are close. I believe, yes, it's a good moment to START doing COST-AVERAGE. The price is...
This week has been phenomenal for AbbVie Inc after researchers found that the large-cap pharma's cholesterol-lowering drug Tricor could work against SARS-CoV2, the virus that causes COVID-19. Key Trading Plan: Wait for the pull back to the Fibonacci 23% at 92.00 before the price rallies back up to the potential resistance of 106.00 ‼️Disclaimer: Please be...
Biotechnology and pharmaceutical companies have been quickly cycling through overbought and oversold. The problem has been so problematic that Sorrento Therapeutics had to specifically claim they were not a “pump and dump” scheme. Any whisper of a "cure" for Covid-19 has investors rushing to the entrance and quickly fleeing after results are what they had expected...
NYSE:ABBV should see a few day run if the signal holds by the end of the day. Needs to close above open price and remain positive for the day. Let's see! The signal is pretty strong here. this is a swing trade idea
based on the chart presented above: ABBV closed on a nice spinning top candle stick, with divergence between oscillators and stock's lower lows. If stock takes purple trend line (resistance) ill buy an small ITM position
NYSE:ABBV Watching that short on NYSE:ABBV Healthcare industry currently on a retracement. #stocks #shares Cheers, G. TS: smartalphatrade
One of my absolute favorite stocks for the next 3 years: ABBV. I'm letting it come down a bit before initiating a position. My model says that there is going to be heavy buying between 74 and 79 which is where I will start accumulation. If you found this to be insightful or helpful, please show appreciation by hitting that like button. If you want more ideas I...
ABBV has formed a parabolic uptrend, with the presence of a falling wedge, which has led to a major bullish breakout, however still within the parabolic trend range. MACD also indicates a reversal taking place.
I would close this trade at this point if I were swing trading. If you bought in in the green support area from august, it would have been about a 35-40% gain on this one.
Waiting for confirmation - trend break. just my interpretation. (not advice) hoping to go long. Target of 97.9
Really nice reversal in ABBV over the past 2+ months. Rose through descending channel resistance AND ascending trendline resistance, then re-tested support and took off. It's probably due for a breather, but I'd be a buyer if it re-tests support once more around $74.
ABBV is currently breaking the 200sma, ending a 14 month downtrend. On the next days I will be tracking the next tools: OBV should trend higher to confirm this new uptrend. It still has not done that. 3 candlestick closes above the 200SMA would also be a confirmation signal.
Regenerative medicine company developing novel placenta-based cell therapy products. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic...
ABBV took a sharp dip with the recent news, but at the end of the day, they will just grow bigger. From a technicial analysis stand point, ABBV remains ina decending wedge, even with the sharp decline in price. Lower risk entry would be confirmed brakeout above the wedge. I may be interested in a swing trade between the .786 and .382 fibs. This could potentially...
After moving 40% down from ATH's has abbv found support on this slope support & 61.8% retrace? 4h levels show the channel structure in place. First test to upside comes at $82.5 which has been key pivot level.
Watching for ABBV to break this wedge and go higher to fill the gap from earnings.